Evaluation of the effect of Gabapentin on post-operative pain in patients undergoing Caesarean section under spinal anesthesia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230311057674N1

Enrollment

Registered

2024-05-26

Start date

2024-06-21

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caesarean section. Encounter for Caesarean section without indication

Interventions

Intervention group: Gabapentin 600 mg orally and the second group received placebo one hour before the operation..

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Pregnant mother first pregnancy with I ASA and age 18-40 who is a candidate for elective caesarean section and Spanish anesthesia.

Exclusion criteria

Exclusion criteria: There is no history of any neurological disease and calcium channel blocker in recent month and contraindication of Gabapentin and without spinal contraindication criteria, coagulation defects, history of sensitivity to local anesthetics, noncooperation and local infection.

Design outcomes

Primary

Measure	Time frame
Severity of pain after caesarean section in patients. Timepoint: 6, 12, and 24 hours after the operation. Method of measurement: It will be evaluated using the Visual Analogue Scale (VAS) questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdieh Jafari

Mashhad University of Medical Sciences

jafarimh@mums.ac.ir+98 51 3879 5031

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026